307 related articles for article (PubMed ID: 8943078)
1. Brain drug delivery of small molecules using immunoliposomes.
Huwyler J; Wu D; Pardridge WM
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14164-9. PubMed ID: 8943078
[TBL] [Abstract][Full Text] [Related]
2. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
Huwyler J; Yang J; Pardridge WM
J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
[TBL] [Abstract][Full Text] [Related]
3. Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects.
Schnyder A; Krähenbühl S; Drewe J; Huwyler J
J Drug Target; 2005 Jun; 13(5):325-35. PubMed ID: 16199376
[TBL] [Abstract][Full Text] [Related]
4. Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system.
Cerletti A; Drewe J; Fricker G; Eberle AN; Huwyler J
J Drug Target; 2000; 8(6):435-46. PubMed ID: 11328669
[TBL] [Abstract][Full Text] [Related]
5. Targeting of skeletal muscle in vitro using biotinylated immunoliposomes.
Schnyder A; Krähenbühl S; Török M; Drewe J; Huwyler J
Biochem J; 2004 Jan; 377(Pt 1):61-7. PubMed ID: 14516278
[TBL] [Abstract][Full Text] [Related]
6. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.
Maruyama K; Takizawa T; Yuda T; Kennel SJ; Huang L; Iwatsuru M
Biochim Biophys Acta; 1995 Mar; 1234(1):74-80. PubMed ID: 7880861
[TBL] [Abstract][Full Text] [Related]
7. Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease.
Kang YS; Jung HJ; Oh JS; Song DY
CNS Neurosci Ther; 2016 Oct; 22(10):817-23. PubMed ID: 27350533
[TBL] [Abstract][Full Text] [Related]
8. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
Désormeaux A; Bergeron MG
Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
[TBL] [Abstract][Full Text] [Related]
9. Tumor targeting using anti-her2 immunoliposomes.
Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
[TBL] [Abstract][Full Text] [Related]
10. Dual ligand immunoliposomes for drug delivery to the brain.
Loureiro JA; Gomes B; Fricker G; Cardoso I; Ribeiro CA; Gaiteiro C; Coelho MA; Pereira Mdo C; Rocha S
Colloids Surf B Biointerfaces; 2015 Oct; 134():213-9. PubMed ID: 26204501
[TBL] [Abstract][Full Text] [Related]
11. PEGylated immunoliposomes directed against brain astrocytes.
Chekhonin VP; Zhirkov YA; Gurina OI; Ryabukhin IA; Lebedev SV; Kashparov IA; Dmitriyeva TB
Drug Deliv; 2005; 12(1):1-6. PubMed ID: 15801714
[TBL] [Abstract][Full Text] [Related]
12. Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion.
Gosk S; Vermehren C; Storm G; Moos T
J Cereb Blood Flow Metab; 2004 Nov; 24(11):1193-204. PubMed ID: 15545912
[TBL] [Abstract][Full Text] [Related]
13. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
[TBL] [Abstract][Full Text] [Related]
14. [Study on preparation and biodistribution of PEG-immunoliposomes with active carboxylic terminals].
Zhang YF; Xie SS; Hou XP; Gao X; Zhang S; Chen ZS
Yao Xue Xue Bao; 2000 Nov; 35(11):854-9. PubMed ID: 11218866
[TBL] [Abstract][Full Text] [Related]
15. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
Kang YS; Pardridge WM
J Pharmacol Exp Ther; 1994 Apr; 269(1):344-50. PubMed ID: 8169841
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes.
Harding JA; Engbers CM; Newman MS; Goldstein NI; Zalipsky S
Biochim Biophys Acta; 1997 Jul; 1327(2):181-92. PubMed ID: 9271260
[TBL] [Abstract][Full Text] [Related]
17. Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
Maruyama K; Kennel SJ; Huang L
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5744-8. PubMed ID: 2377612
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro targeting of sterically stabilized liposomes modified with chimeric TNT-3 monoclonal antibody.
Pan H; Niu GQ; Pan J; Lu WY
Yao Xue Xue Bao; 2006 Jun; 41(6):506-12. PubMed ID: 16927823
[TBL] [Abstract][Full Text] [Related]
19. Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model.
Tseng YL; Hong RL; Tao MH; Chang FH
Int J Cancer; 1999 Mar; 80(5):723-30. PubMed ID: 10048974
[TBL] [Abstract][Full Text] [Related]
20. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
Nam SM; Kim HS; Ahn WS; Park YS
Oncol Res; 1999; 11(1):9-16. PubMed ID: 10451027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
